Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Active not recruiting 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Carcinoma, Non-Small-Cell Lung 19Lung Neoplasms 11Squamous Cell Carcinoma of Head and Neck 8Prostatic Neoplasms 6Prostatic Neoplasms, Castration-Resistant 4Stomach Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Endometrial Neoplasms 3Carcinoma, Transitional Cell 3Breast Neoplasms 3Urinary Bladder Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Melanoma 2Lymphoid Interstitial Pneumonia 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Carcinoma 2Vaccinia 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Non-muscle Invasive Bladder Cancer With Carcinoma in Situ 1Neoplasms by Site 1Neoplasms by Histologic Type 1

Interventions

Platinum 2Immunoglobulin G 2Docetaxel 2Disulfides 2Cisplatin 2Carboplatin 2Bevacizumab 21,2-diaminocyclohexaneplatinum II citrate 2dehydroftorafur 1atezolizumab 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Fluorouracil 1Cetuximab 1(225)Ac-DOTA-c(RGDyK) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoid Interstitial Pneumonia × Docetaxel × 30 days × Clear all
NCT05063552 2026-06-03

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
430 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT00588770 2026-05-29

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
403 enrolled 10 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡